Long term outcome of hepatitis C viral (HCV) infection in primary adult liver transplant recipients compared to non HCV under tacrolimus

被引：0
|
作者：
Rogers, J [1 ]
Jain, A [1 ]
DeVera, M [1 ]
Yelochan, B [1 ]
Rakela, J [1 ]
Fung, J [1 ]
机构：
[1] Thomas E Starzl Transplantat Inst, Pittsburgh, PA 15213 USA
来源：
TRANSPLANTATION | 1999年 / 67卷 / 07期
关键词：
D O I：
10.1097/00007890-199904150-00063
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
35
引用
收藏
页码：S15 / S15
页数：1
相关论文
共 50 条
  • [31] Pharmacokinetics of mycophenolic acid and clinical outcomes in liver transplant recipients with hepatitis C (HCV).
    Sievers, TM
    Holt, CD
    Ghopbrial, RM
    Artinian, L
    McDiarmid, SV
    Busuttil, RW
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 473 - 473
  • [32] Pharmacokinetics of mycophenolic acid and clinical outcomes in liver transplant recipients with hepatitis C (HCV).
    Sievers, TM
    Holt, CD
    Ghobrial, RM
    Artinian, L
    McDiarmid, SV
    Busuttil, RW
    LIVER TRANSPLANTATION, 2005, 11 (07) : C25 - C25
  • [33] Virological and histological features of hepatitis C virus (HCV) infection in kidney transplant recipients
    Fabrizi, F
    Lunghi, G
    Marai, P
    Marcelli, D
    Guarnori, I
    Raffaele, L
    Erba, G
    Pagano, A
    Locatelli, F
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 (01) : 159 - 164
  • [34] Antiviral treatment induced loss of HCV loads predicts long-term survival in liver transplant recipients with recurrent hepatitis C
    Kornberg, Arno
    Kuepper, Bernadett
    Baerthel, Erik
    Wilberg, Jens
    Thrum, Katharina
    Settmacher, Utz
    TRANSPLANT INTERNATIONAL, 2007, 20 : 42 - 42
  • [35] LONG-TERM FOLLOW-UP OF HEPATITIS-C VIRUS (HCV) INFECTION IN LIVER-TRANSPLANT PATIENTS
    VILLA, E
    GROTTOLA, A
    BUTTAFOCO, P
    MERIGHI, A
    FERRETTI, I
    TRANDE, P
    ZOBOLI, P
    CAMELLINI, L
    CALLEA, F
    DEPALMA, M
    VECCHI, C
    TROISI, R
    CAMISASCA, M
    ROSSI, S
    TORDATO, G
    DEHEMPTINNE, B
    PODDA, M
    MANENTI, F
    CLINICAL TRANSPLANTATION, 1995, 9 (03) : 160 - 164
  • [36] Pharmacokinetics of mycophenolic acid and clinical outcomes in liver transplant recipients with hepatitis C (HCV).
    Sievers, TM
    Holt, CD
    Ghobrial, RM
    Artinian, L
    McDiarmid, SV
    Busuttil, RW
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 365 - 365
  • [37] Outcomes of Hepatitis C Positive (HCV plus ) Kidney Transplant Recipients Compared to Hepatitis C Negative (HCV-) Recipients. An Analysis of the OPTN/UNOS Database.
    Kassis, N.
    Khalil, A.
    Taber, T.
    Yaqub, M.
    Mishler, D.
    Mujtaba, M.
    Sharfuddin, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 622 - 622
  • [38] Long-term maintenance of SVR in difficult-to-treat HCV genotypes in liver transplant recipients with HCV recurrence
    Ponziani, Francesca Romana
    Milani, Alessandro
    Gasbarrini, Antonio
    Zaccaria, Raffaella
    Vigano, Raffaella
    Iemmolo, Rosa Maria
    Donato, Maria F.
    Rendina, Maria
    Toniutto, Pierluigi
    Pasulo, Luisa
    Morelli, Maria Cristina
    Burra, Patrizia
    Miglioresi, Lucia
    Merli, Manuela
    Di Paolo, Daniele
    Fagiuoli, Stefano
    Pompili, Maurizio
    HEPATOLOGY, 2012, 56 : 1004A - 1004A
  • [39] SURVIVAL AND PROGRESSION OF FIBROSIS IN HISPANIC AND NON-HISPANIC LIVER TRANSPLANT (LT) RECIPIENTS WITH HEPATITIS C (HCV)
    Verna, Elizabeth C.
    Valadao, Rosa M.
    Farrand, Erica
    Pichardo, Elsa
    Lai, Jennifer C.
    Terrault, Norah
    Brown, Robert S.
    HEPATOLOGY, 2009, 50 (04) : 550A - 550A
  • [40] Effect of Hepatitis C Virus (HCV) Infection on the Outcome of Highly Sensitized Kidney Transplant Recipients in Modern Immunosuppression Era
    Linatoc, J. A. T.
    Ren, Q.
    Behnke, M.
    Sharma, A.
    Posner, M.
    Gehr, T.
    King, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 172 - 172
12345